Lipopolysaccharide neutralization by the antibacterial peptide CM4

European Journal of Pharmacology

Volumn 596, Issue 1-3, 2008, Pages 160-165

  Lin, Qing Ping ^a   Zhou, Liang Fan ^a   Li, Nan Nan ^a   Chen, Yu Qing ^a   Li, Bao Cun ^a   Cai, Yu Feng ^a   Zhang, Shuang Quan ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

CM4; Inflammation; LPS (Lipopolysaccharide); Neutralization

Indexed keywords

CD14 ANTIGEN; CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE; PEPTIDE CM4; POLYPEPTIDE ANTIBIOTIC AGENT; PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BACTERICIDAL ACTIVITY; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG MECHANISM; DRUG PROTEIN BINDING; ESCHERICHIA COLI; MOUSE; NONHUMAN; OUTER MEMBRANE; PRIORITY JOURNAL; PROTEIN INDUCTION; SEPTIC SHOCK;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIGENS, CD14; ANTIMICROBIAL CATIONIC PEPTIDES; CELL LINE; CELL SURVIVAL; ESCHERICHIA COLI K12; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; NITRIC OXIDE; PROTEIN BINDING; TUMOR NECROSIS FACTOR-ALPHA;

EID: 53049110125     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.08.017     Document Type: Article

References (29)

1. Beutler B., Milsark I.W., and Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229 (1985) 869-871
2. Bohrer D., Horner R., Nascimento P.C., Adaime M., Pereira M.E., Martins A.F., and Hartz S.A. Interference in the limulus amebocyte lysate assay for endotoxin determination in peritoneal dialysis fluids and concentrates for hemodialysis. J. Pharm. Biomed. Anal. 26 (2001) 811-818
3. Byl B., Clevenbergh P., Kentos A., Jacobs F., Marchant A., Vincent J., and Thys J. Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections. Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 804-807
4. Chakravortty D., and Kumar K.S.N. Induction of cell proliferation and collagen synthesis in human small intestinal lamina propria fibroblasts by lipopolysaccharide: possible involvement of nitric oxide. Biochem. Biophys. Res. Commun. 240 (1997) 458-463
5. Chen Y.Q., Zhang S.Q., Li B.C., Qiu W., Jiao B., Zhang J., and Diao Z.Y. Expression of a cytotoxic cationic antibacterial peptide in Escherichia coli using two fusion partners. Protein Expr. Purif. 57 (2008) 303-311
6. Ciornei C.D., Sigurdardo'ttir T., Schimdtchen A., and Bodelsson M. Antimicrobial and chemoattractant activity, lipopolysaccharide neutralization, cytotoxicity, and inhibition by serum of analogs of human cathelicidin LL-37. Antimicrob. Agents Chemother. 49 (2005) 2845-2850
7. Cohen J. The immunopathogenesis of sepsis. Nature 420 (2002) 885-891
8. Ding L., Yang L., Weiss T.M., Waring A.J., Lehrer R.I., and Huang H.W. Interaction of antimicrobial peptides with lipopolysaccharides. Biochemistry 42 (2003) 12251-12259
9. Dobrovolskaia M.A., and Vogel S.N. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes. Infect. 4 (2002) 903-914
10. Fessler M.B., Malcolm K.C., Duncan M.W., and Worthen G.S. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J. Biol. Chem. 277 (2002) 31291-31302
11. Finlay B.B., and Hancock R.E. Can innate immunity be enhanced to treat microbial infections?. Nat. Rev. Microbiol. 2 (2004) 497-504
12. Freeman B.D., and Natanson C. Anti-inflammatory therapies in sepsis and septic shock. Expet. Opin. Investig. Drugs 9 (2000) 1651-1663
13. Giacometti A., Cirioni O., Ghiselli R., Moccheggiani F., D'Amato G., Circo T., Orlando F., Skerlavaj B., Silvestri C., Saba V., Zanetti M., and Scalise G. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. Am. J. Respir. Crit. Care Med. 169 (2004) 187-194
14. Giacometti A., Cirioni O., Ghiselli R., Mocchegiani F., Orlando F., Silvestri C., Bozzi A., Giulio A.D., Luzi C., Mangoni M.L., Barra D., Saba V., Scalise G., and Rinaldi A.C. Interaction of antimicrobial peptide Temporin L with lipopolysaccharide in vitro and in experimental rat models of septic shock caused by gram-negative bacteria. Antimicrob. Agents Chemother. 50 (2006) 2478-2486
15. Hancock R.E.W., and Scott M.G. The role of antimicrobial peptides in animal defenses. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 8856-8861
16. Hardaway R.M. A review of septic shock. Am. Surg. 66 (2000) 22-29
17. Hartung T., Fennrich S., Fischer M., Montag-Lessing T., and Wendel A. Development and evaluation of a pyrogen test based on human whole blood. ALTEX 15 (1998) 9-10
18. Li B.C., Zhang S.Q., Dan W.B., Chen Y.Q., and Cao P. Expression in Escherichia coli and purification of bioactive antibacterial peptide ABP-CM4 from the Chinese silk worm, Bombyx mori. Biotechnol. Lett. 29 (2007) 1031-1036
19. Li P., Wohland T., Ho B., and Ding J.L. Perturbation of lipopolysaccharide (LPS) micelles by sushi 3 (S3) antimicrobial peptide. J. Biol. Chem. 48 (2004) 50150-50156
20. Matsuura K., Setoguchi M., Nasu N., Higuchi Y., Yoshida S., Akizuki S., and Yamamoto S. Nucleotide and amino acid sequences of the mouse CD14 gene. Nucleic Acids Res. 17 (1989) 2132
21. + cells. J. Immunol. 167 (2001) 3329-3338
22. Palsson-McDermott E.M., and O'Neill L.A.J. Signal transduction by the lipopolysaccharide receptor, toll-like receptor-4. Immunology 113 (2004) 153-162
23. Papo N., and Shai Y. A molecular mechanism for lipopolysaccharide protection of Gram-negative bacteria from antimicrobial peptides. J. Biol. Chem. 280 (2005) 10378-10387
24. Raetz C.R.H., and Whitfield C. Lipopolysaccharide endotoxins. Annu. Rev. Biochem. 71 (2002) 635-700
25. Ried C., Wahl C., Miethke T., Wellnhofer G., Landgraf C., Schneider-Mergener J., and Hoess A. High affinity endotoxin-binding and neutralizing peptides based on the crystal structure of recombinant Limulus antilipopolysaccharide factor. J. Biol. Chem. 271 (1996) 28120-28127
26. Rosenfeld Y., Papo N., and Shai Y. Endotoxin (lipopolysaccharide) Neutralization by innate immunity host-defense peptides. J. Biol. Chem. 281 (2006) 1636-1643
27. Tu Y.Z., Zhang S.Q., and Qu X.M. Separation, purification of antibacterial CM4 and the research of the structure and character. Sci. China B 32 (1989) 473-480
28. Xu J., and Zhang S. The mechanism of antibacterial peptide CM4 component was observed by confocal laser scanning microscope. Prog. Nat. Sci. 10 (2001) 1105-1109
29. Zhang S.Q., Jia H.W., and Dai Z.Y. Ultrastructure observation of K562 leukemia cells treated with antibacterial peptide CM4 component. Prog. Biochem. Biophys. 24 (1997) 159-163